PATIENT PROFILES

When topicals aren't enough,
start with SOTYKTU

For your moderate-to-severe plaque psoriasis
patients who are candidates for systemic therapy1

Possible plaque psoriasis patient prescribed Sotyktu in blue shirt

Review patient profiles

SOTYKTU is a once-daily, oral first-line treatment option for your appropriate adult moderate-to-severe plaque psoriasis patients.

Potential Sotyktu patient Zach
Meet Zach, a novice runner whose topical treatment is no longer working for him

"I want to make running part of my daily routine, but my clothes chafe against my skin, cutting my runs short."

lime green bars
Potential Sotyktu patient Megan
Meet Megan, a teacher with visible scalp involvement who may be a candidate for SOTYKTU

"I constantly think about the plaques on my scalp when talking to the parents of my students, and I am afraid it is going to get worse."

ARE YOU READY TO EXPLORE MORE? SELECT A TOPIC BELOW.


SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU logo are trademarks of Bristol-Myers Squibb Company.
This site is intended for U.S. Healthcare Professionals only.
Otezla is a registered trademark of Amgen Inc.
© 2025 Bristol-Myers Squibb Company.
1787-US-2400641 11/24

1787-US-2400887 02/25